Zentalis Pharmaceuticals, Inc. (ZNTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 97.02M |
| Enterprise Value | 100.61M |
| P/E Ratio | -0.94 |
| PEG Ratio | -0.19 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.74 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.52 |
| Return On Equity | -0.76 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -144.27M |
| Net Income | -137.06M |
| Diluted EPS | -1.91 |
| Total Cash | 228.89M |
| Total Cash/Share | 2.71 |
| Total Debt | 32.44M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 7.33 |
| Book Value Per Share | 2.42 |
| 52-Week Change | 36.36 |
| 52-Week High | 6.95 |
| 52-Week Low | 1.25 |
| Moving Average 50 Days | 2.7 |
| Moving Average 200 Days | 3.42 |
| Average Volume | 1.25M |
| Shares Outstanding | 94.67M |
| % Held by Institutions | 67.68 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |